WestCX Launches RCS and Dynamic QR Solutions to Enhance Patient Engagement at Becker’s Health IT Conference

WestCX launched RCS and Dynamic QR solutions to enhance patient engagement and operational efficiency at Becker’s Health IT Conference.

Quiver AI Summary

WestCX, a part of the West Technology Group, has launched its Rich Communication Services (RCS) and Dynamic QR capabilities at the Becker’s Health IT + Digital Health + RCM Annual Meeting. These innovative solutions, offered through the TeleVox and Mosaicx brands, aim to enhance patient engagement in healthcare while reducing costs and improving revenue capture. The early adoption of these technologies has resulted in significantly higher conversion rates, increased revenue from reduced no-shows, and enhanced engagement through interactive features, all while maintaining compliance with key regulatory standards. Sam Meckey, president of WestCX, emphasized the importance of these tools in addressing the growing demands of clinical and financial performance. Attendees at Becker’s can see these solutions in action at Booth 617, with options for virtual demonstrations available as well.

Potential Positives

Launch of Rich Communication Services (RCS) and Dynamic QR capabilities enhances patient engagement and operational efficiency for healthcare organizations.
Early deployments have shown promising results with 50–80% higher conversions compared to traditional SMS/email, indicating strong demand and effectiveness of the new solutions.
The solutions help clients achieve approximately 20% revenue uplift through reduced no-shows and improved patient adherence, showcasing substantial financial benefits.
Full compliance with HITRUST, HIPAA, SOC 2, and PCI standards positions WestCX as a trustworthy partner in the healthcare sector, appealing to regulatory demands and client confidence.

Potential Negatives

Announcement lacks measurable details on the concrete impact of the new RCS and Dynamic QR capabilities, limiting assessment of their actual effectiveness.
Potential over-reliance on AI and automation could raise concerns about the personal touch in patient interactions and could lead to pushback from healthcare providers.
The emphasis on revenue generation and cost reduction may inadvertently suggest a prioritization of profits over patient care in a sensitive industry.

FAQ

What are RCS and Dynamic QR capabilities?

RCS and Dynamic QR entail innovations that enhance patient engagement and streamline operations for healthcare providers and payors.

How does WestCX support healthcare compliance?

WestCX's solutions ensure full compliance with HITRUST, HIPAA, SOC 2, and PCI standards while improving engagement and revenue.

Where can I see WestCX's demonstration?

You can see the demonstration of RCS and Dynamic QR at Booth 617 during the Becker’s Health IT + Digital Health + RCM Conference.

What benefits do RCS and Dynamic QR offer?

These solutions provide higher conversion rates, reduced no-show rates, increased engagement, and quicker ROI for healthcare organizations.

How can I schedule a demo of WestCX solutions?

You can schedule a virtual demo by visiting www.televox.com/request-a-demo/.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$APO Congressional Stock Trading

Members of Congress have traded $APO stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $APO stock by members of Congress over the last 6 months:

REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$APO Insider Trading Activity

$APO insiders have traded $APO stock on the open market 8 times in the past 6 months. Of those trades, 2 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $APO stock by insiders over the last 6 months:

LEON D BLACK has made 0 purchases and 2 sales selling 1,522,725 shares for an estimated $190,334,976.
2018 GST TRUST LB purchased 607,725 shares for an estimated $67,697,526
MARTIN KELLY (Chief Financial Officer) has made 0 purchases and 3 sales selling 19,500 shares for an estimated $2,779,502.
WHITNEY CHATTERJEE (Chief Legal Officer) sold 4,500 shares for an estimated $657,148
PAULINE RICHARDS purchased 550 shares for an estimated $78,071

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$APO Hedge Fund Activity

We have seen 602 institutional investors add shares of $APO stock to their portfolio, and 447 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

VICTORY CAPITAL MANAGEMENT INC added 2,230,750 shares (+1670.1%) to their portfolio in Q2 2025, for an estimated $316,476,502
BLACKROCK, INC. removed 2,177,928 shares (-6.1%) from their portfolio in Q2 2025, for an estimated $308,982,645
CAPITAL RESEARCH GLOBAL INVESTORS added 1,887,106 shares (+26.5%) to their portfolio in Q2 2025, for an estimated $267,723,728
D. E. SHAW & CO., INC. removed 1,569,337 shares (-94.4%) from their portfolio in Q2 2025, for an estimated $222,641,840
BOSTON PARTNERS removed 1,189,444 shares (-43.7%) from their portfolio in Q2 2025, for an estimated $168,746,420
ALLIANCEBERNSTEIN L.P. removed 1,168,627 shares (-47.2%) from their portfolio in Q2 2025, for an estimated $165,793,112
NORGES BANK removed 1,167,841 shares (-14.8%) from their portfolio in Q2 2025, for an estimated $165,681,602

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$APO Analyst Ratings

Wall Street analysts have issued reports on $APO in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Wells Fargo issued a "Overweight" rating on 07/11/2025
Citigroup issued a "Buy" rating on 07/10/2025
Piper Sandler issued a "Overweight" rating on 05/05/2025
Barclays issued a "Overweight" rating on 05/05/2025
TD Cowen issued a "Buy" rating on 04/09/2025
B of A Securities issued a "Buy" rating on 04/04/2025

To track analyst ratings and price targets for $APO, check out Quiver Quantitative's $APO forecast page.

$APO Price Targets

Multiple analysts have issued price targets for $APO recently. We have seen 10 analysts offer price targets for $APO in the last 6 months, with a median target of $164.0.

Here are some recent targets:

Glenn Schorr from Evercore ISI Group set a target price of $160.0 on 08/06/2025
Michael Brown from Wells Fargo set a target price of $173.0 on 07/11/2025
Christopher Allen from Citigroup set a target price of $170.0 on 07/10/2025
Benjamin Budish from Barclays set a target price of $168.0 on 07/10/2025
John Barnidge from Piper Sandler set a target price of $174.0 on 05/05/2025
Benjamin Rubin from UBS set a target price of $155.0 on 05/01/2025
Michael Cyprys from Morgan Stanley set a target price of $131.0 on 04/14/2025

Full Release

OMAHA, Neb., Sept. 30, 2025 (GLOBE NEWSWIRE) -- WestCX, part of the West Technology Group , today announced the launch of its Rich Communication Services (RCS) and Dynamic QR capabilities at the Becker’s Health IT + Digital Health + RCM Annual Meeting (Booth 617). Available through its TeleVox and Mosaicx brands, these innovations help healthcare providers, payors, and life sciences organizations improve patient engagement, reduce costs, capture more revenue, and meet the strictest compliance standards.

Measurable Outcomes
RCS and Dynamic QR are designed to address the dual pressures of clinical excellence and financial performance. Early deployments have delivered:

50–80% higher conversions compared to SMS/email
~20% revenue uplift from fewer no-shows and improved adherence
3× engagement increases through branded quick replies and interactive features
Full compliance with HITRUST, HIPAA, SOC 2, and PCI standards

“The convergence of regulatory demands and clinical expectations has never been greater,” said Sam Meckey, president of WestCX. “RCS and Dynamic QR give health organizations the ability to lower costs, boost outcomes, and capture revenue without ever compromising compliance.”

For clinicians, these solutions reduce manual outreach and support better adherence. For operational and financial leaders, they mean greater margin protection, auditability, and faster ROI.

“This is part of our larger vision to make every patient or member interaction secure, intelligent, and predictive,” Meckey added. “It’s how WestCX is helping healthcare move from transactional communication to personalized, AI-native engagement.”

Live at Becker’s
WestCX’s TeleVox team will demonstrate RCS and Dynamic QR at Booth 617 during Becker’s Health IT + Digital Health + RCM Conference in Chicago (September 30–October 3). Attendees can see firsthand how these tools transform clinical workflows, revenue cycle operations, and patient engagement.

Can’t attend Becker’s? Schedule a virtual demo at www.televox.com/request-a-demo/ .

About WestCX
WestCX, under the West Technology Group, LLC portfolio, is a cloud-based technology partner providing AI-powered omnichannel solutions. The WestCX brand includes Mosaicx and TeleVox, solutions that automate interactions and optimize engagements, improving efficiency and customer and patient satisfaction. With over 30 years of experience delivering enterprise CX solutions, the company’s expertise includes innovative digital patient relationship management and conversational AI solutions. West Technology Group is controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO).

Media Contact
Lucy Meneghello
Communiqué PR
[email protected]
206-282-4923 ext. 129